dysfunction. This is a dose ranging, multicenter, randomized, double-blind, placebo-controlled, home use, parallel group clinical trial of MED2002, which is a topical gel developed by UK-based pharmaceutical company Futura Medical. The study’s participants are...
Join an industry expert in this free webinar to learn about trends in the clinical trial supply chain landscape and how sponsors can adapt and respond to change using new approaches to supply chain management. The clinical trial supply chain landscape is constantly...
IQVIA™ (NYSE:IQV) announces its launch of the IQVIA Patient Portal, a global web-based solution built on a leading health cloud platform. This innovative tool enables increases in clinical trial patient recruitment, engagement and retention by ensuring transparency...
With over 2.40 billion monthly active users, Facebook stands as the largest social media platform in the world. It also boasts a user base that, collectively, comes from different regions, ranging from the United States to Canada to Asia. For patient recruitment...
Study met primary endpoint, verified HRS-1 reversal including three components: renal function improvement, avoidance of dialysis and short-term survival CONFIRM is the largest-ever prospective study (n=300) conducted in patients with HRS-1, an acute and rare disease...
VistaGen Therapeutics (VTGN), a clinical-stage biopharmaceutical company developing new generation medicines for central nervous system (CNS) diseases and disorders with high unmet need, announced today that the Company has achieved completion of target patient...
Email
Text